Iran vs MENA Programme Region: Percentage of surviving infants who received the first dose of
Iran
99
in 2025
MENA Programme Region
84
in 2025
Iran rank
1st
MENA Programme Region rank
2nd
Percentage of surviving infants who received the first dose of over time
- Iran
- MENA Programme Region
How they compare
Iran currently reports 99 against 84 in MENA Programme Region, a difference of 15.
That makes Iran's figure about 1.2 times MENA Programme Region's.
The two have swapped places 2 times across 46 shared years of data; in 1980 it was Iran ahead.
Iran ranks 1st and MENA Programme Region ranks 2nd of 20 countries.
Iran has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Iran | MENA Programme Region | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 55.2 | 45.5 | 9.7 | Iran |
| 1990s | 94.5 | 80.6 | 13.9 | Iran |
| 2000s | 97.6 | 85.8 | 11.8 | Iran |
| 2010s | 98.8 | 88.7 | 10.1 | Iran |
| 2020s | 99 | 84.17 | 14.83 | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of surviving infants who received the first dose of, Iran or MENA Programme Region?
- Iran, at 99 against 84 in MENA Programme Region as of 2025.
- What is the difference in percentage of surviving infants who received the first dose of between Iran and MENA Programme Region?
- 15, with Iran ahead.
- How many years of comparable data are there for Iran and MENA Programme Region?
- 46 years are reported by both, from 1980 to 2025.
- How do Iran and MENA Programme Region rank globally for percentage of surviving infants who received the first dose of?
- Iran ranks 1st and MENA Programme Region ranks 2nd of 20 countries.
- Where does this data come from?
- UNICEF, published as Percentage of surviving infants who received the first dose of measles-containing vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.